Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

BioPlus Acquisition (BIOS)

BioPlus Acquisition Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BIOS
DateTimeSourceHeadlineSymbolCompany
04/10/202312:30GlobeNewswire Inc.BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to LiquidateNASDAQ:BIOSBioPlus Acquisition Corporation
04/10/202312:30GlobeNewswire Inc.Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business CombinationNASDAQ:BIOSBioPlus Acquisition Corporation
16/08/202313:30GlobeNewswire Inc.Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient MonitoringNASDAQ:BIOSBioPlus Acquisition Corporation
17/07/202313:00GlobeNewswire Inc.Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical’s Board of DirectorsNASDAQ:BIOSBioPlus Acquisition Corporation
14/06/202311:09Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSBioPlus Acquisition Corporation
14/06/202311:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSBioPlus Acquisition Corporation
13/06/202313:30GlobeNewswire Inc.Avertix’s Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth OrlandoNASDAQ:BIOSBioPlus Acquisition Corporation
30/05/202321:04Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSBioPlus Acquisition Corporation
19/05/202321:50Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSBioPlus Acquisition Corporation
19/05/202321:05Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSBioPlus Acquisition Corporation
15/05/202321:29Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSBioPlus Acquisition Corporation
15/05/202311:38Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:BIOSBioPlus Acquisition Corporation
12/05/202321:17Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BIOSBioPlus Acquisition Corporation
03/05/202313:47Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSBioPlus Acquisition Corporation
03/05/202313:44Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSBioPlus Acquisition Corporation
03/05/202313:30GlobeNewswire Inc.Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition CorporationNASDAQ:BIOSBioPlus Acquisition Corporation
27/04/202321:35Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:BIOSBioPlus Acquisition Corporation
14/02/202320:39Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIOSBioPlus Acquisition Corporation
02/02/202315:10Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BIOSBioPlus Acquisition Corporation
03/11/202221:10Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSBioPlus Acquisition Corporation
11/10/202221:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSBioPlus Acquisition Corporation
10/08/202221:33Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSBioPlus Acquisition Corporation
12/05/202221:55Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSBioPlus Acquisition Corporation
11/03/202221:05Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BIOSBioPlus Acquisition Corporation
09/02/202219:14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIOSBioPlus Acquisition Corporation
06/12/202113:00GlobeNewswire Inc.BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public OfferingNASDAQ:BIOSBioPlus Acquisition Corporation
03/12/202101:55GlobeNewswire Inc.BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public OfferingNASDAQ:BIOSBioPlus Acquisition Corporation
03/02/202013:30GlobeNewswire Inc.Option Care Health Completes Reverse Stock Split and Ticker Symbol ChangeNASDAQ:BIOSBioPlus Acquisition Corporation
26/12/201921:24GlobeNewswire Inc.RLH Corporation Appoints R. Carter Pate as ChairmanNASDAQ:BIOSBioPlus Acquisition Corporation
18/12/201914:22GlobeNewswire Inc.Option Care Health to Participate in the 38th Annual J.P. Morgan Healthcare ConferenceNASDAQ:BIOSBioPlus Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:BIOS